Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 February;56(1)

ULTIMO FASCICOLOTHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


Periodicità: Trimestrale

ISSN 1824-4785

Online ISSN 1827-1936


eTOC

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 February;56(1)

 FOREWORD THE IMPACT OF MOLECULAR IMAGING ON THE MANAGEMENT OF MOVEMENT DISORDERS 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 February:56(1):1-3

The impact of molecular imaging in the management of movement disorders: an ongoing revolution

Nobili F., Tatsch K.


 REVIEWS THE IMPACT OF MOLECULAR IMAGING ON THE MANAGEMENT OF MOVEMENT DISORDERS 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 February:56(1):4-16

The molecular basis of dopaminergic brain imaging in Parkinson’s disease

Seibyl J., Russell D., Jennings D., Marek K.


 REVIEWS THE IMPACT OF MOLECULAR IMAGING ON THE MANAGEMENT OF MOVEMENT DISORDERS 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 February:56(1):17-26

The role of molecular imaging in the differential diagnosis of parkinsonism

Booij J., Teune L. K., Verberne H. J.


 REVIEWS THE IMPACT OF MOLECULAR IMAGING ON THE MANAGEMENT OF MOVEMENT DISORDERS 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 February:56(1):27-38

Quantitative approaches to dopaminergic brain imaging

Tatsch K., Poepperl G.


 REVIEWS THE IMPACT OF MOLECULAR IMAGING ON THE MANAGEMENT OF MOVEMENT DISORDERS 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 February:56(1):39-54

Identification of biomarkers in Lewy-body disorders

Warr L., Walker Z.


 REVIEWS THE IMPACT OF MOLECULAR IMAGING ON THE MANAGEMENT OF MOVEMENT DISORDERS 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 February:56(1):55-67

Cognitive impairment in degenerative parkinsonisms: role of radionuclide brain imaging

Arnaldi D., Morbelli S., Morrone E., Campus C., Nobili F.


 REVIEWS THE IMPACT OF MOLECULAR IMAGING ON THE MANAGEMENT OF MOVEMENT DISORDERS 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 February:56(1):68-82

New developments of dopaminergic imaging in Parkinson’s disease

Varrone A., Halldin C.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 February:56(1):83-9

Financial aspects of sentinel lymph node biopsy in early breast cancer

Severi S., Gazzoni E., Pellegrini A., Sansovini M., Raulli G., Corbelli C., Altini M., Paganelli G.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 February:56(1):90-8

Clinical indications to the use of 99mTc-EDDA/HYNIC-TOC to detect somatostatin receptor-positive neuroendocrine tumors

Parisella M. G., Chianelli M., D’Alessandria C., Todino V., Mikolajczak R., Papini E., Dierckx R. A., Scopinaro F., Signore A.


inizio pagina